These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 35226402)
1. 2-Amino-4-aryl-5-oxo-4,5-dihydropyrano[3,2-c]chromene-3-carbonitriles with Microtubule-Disruptive, Centrosome-Declustering, and Antiangiogenic Effects in vitro and in vivo. Köhler LHF; Reich S; Begemann G; Schobert R; Biersack B ChemMedChem; 2022 May; 17(10):e202200064. PubMed ID: 35226402 [TBL] [Abstract][Full Text] [Related]
2. Multimodal 4-arylchromene derivatives with microtubule-destabilizing, anti-angiogenic, and MYB-inhibitory activities. Köhler LHF; Reich S; Yusenko M; Klempnauer KH; Begemann G; Schobert R; Biersack B Cancer Drug Resist; 2023; 6(1):59-77. PubMed ID: 37065868 [No Abstract] [Full Text] [Related]
3. Design, synthesis and characterization of potent microtubule inhibitors with dual anti-proliferative and anti-angiogenic activities. Zhang H; Fang X; Meng Q; Mao Y; Xu Y; Fan T; An J; Huang Z Eur J Med Chem; 2018 Sep; 157():380-396. PubMed ID: 30099258 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of antitumor activity of 9-methoxy-1H-benzo[f]chromene derivatives. Elgaafary M; Lehner J; Fouda AM; Hamed A; Ulrich J; Simmet T; Syrovets T; El-Agrody AM Bioorg Chem; 2021 Nov; 116():105402. PubMed ID: 34670333 [TBL] [Abstract][Full Text] [Related]
5. A New Naphthopyran Derivative Combines Köhler LHF; Reich S; Yusenko M; Klempnauer KH; Shaikh AH; Ahmed K; Begemann G; Schobert R; Biersack B ACS Med Chem Lett; 2022 Nov; 13(11):1783-1790. PubMed ID: 36385941 [TBL] [Abstract][Full Text] [Related]
6. Using Sodium Hydride and Potassium Carbonate as Bases in Synthesis of Substituted 2-Amino-4-aryl-7-propargyloxy-4H-chromene-3-carbonitriles. Thanh ND; Hai DS; Bich VTN; Hien PTT; Duyen NTK; Mai NT; Dung TT; Van HTK; Toan VN; Toan DN; Dang LH Curr Org Synth; 2019; 16(3):423-430. PubMed ID: 31984904 [TBL] [Abstract][Full Text] [Related]
7. 4-Aryl-4H-chromene-3-carbonitrile derivatives: evaluation of Src kinase inhibitory and anticancer activities. Fallah-Tafti A; Tiwari R; Shirazi AN; Akbarzadeh T; Mandal D; Shafiee A; Parang K; Foroumadi A Med Chem; 2011 Sep; 7(5):466-72. PubMed ID: 21801146 [TBL] [Abstract][Full Text] [Related]
8. A proficient microwave synthesis with structure elucidation and the exploitation of the biological behavior of the newly halogenated 3-amino-1H-benzo[f]chromene molecules, targeting dual inhibition of topoisomerase II and microtubules. Fouda AM; Okasha RM; Alblewi FF; Mora A; Afifi TH; El-Agrody AM Bioorg Chem; 2020 Jan; 95():103549. PubMed ID: 31887476 [TBL] [Abstract][Full Text] [Related]
10. Novel 4-Aryl-4H-chromene derivative displayed excellent in vivo anti-glioblastoma efficacy as the microtubule-targeting agent. Yang H; Zhang D; Yuan Z; Qiao H; Xia Z; Cao F; Lu Y; Jiang F Eur J Med Chem; 2024 Mar; 267():116205. PubMed ID: 38350361 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center. Hotchkiss KA; Ashton AW; Mahmood R; Russell RG; Sparano JA; Schwartz EL Mol Cancer Ther; 2002 Nov; 1(13):1191-200. PubMed ID: 12479700 [TBL] [Abstract][Full Text] [Related]
12. DABCO-catalyzed one-pot three component synthesis of dihydropyrano[3,2-c]chromene substituted quinazolines and their evaluation towards anticancer activity. Vodnala S; Bhavani AK; Kamutam R; Naidu VG; Promila ; Prabhakar Ch Bioorg Med Chem Lett; 2016 Aug; 26(16):3973-7. PubMed ID: 27432765 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and potential biological activity of some novel 3-[(N-substituted indol-3-yl)methyleneamino]-6-amino-4-aryl-pyrano(2,3-c)pyrazole-5-carbonitriles and 3,6-diamino-4-(N-substituted indol-3-yl)pyrano(2,3-c)pyrazole-5-carbonitriles. Mandour AH; El-Sawy ER; Ebaid MS; Hassan SM Acta Pharm; 2012 Mar; 62(1):15-30. PubMed ID: 22472446 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel chromene scaffolds for adenosine receptors. Costa M; Areias F; Castro M; Brea J; Loza MI; Proença F Org Biomol Chem; 2011 Jun; 9(11):4242-9. PubMed ID: 21509353 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and In Vitro Cytotoxicity of Novel Halogenated Dihydropyrano[3,2-b]Chromene Derivatives. Sabouri S; Faghih-Mirzaei E; Abaszadeh M Acta Chim Slov; 2022 Dec; 69(4):920-927. PubMed ID: 36562167 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antimicrobial evaluation of new pyrano[4,3-b]pyran and Pyrano[3,2-c]chromene derivatives bearing a 2-thiophenoxyquinoline nucleus. Makawana JA; Patel MP; Patel RG Arch Pharm (Weinheim); 2012 Apr; 345(4):314-22. PubMed ID: 22105795 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, in-vitro cytotoxicity of 1H-benzo[f]chromene derivatives and structure-activity relationships of the 1-aryl group and 9-position. Mohamed HM; Fouda AM; Khattab ESAEH; Agrody AME; Afifi TH Z Naturforsch C J Biosci; 2017 May; 72(5-6):161-171. PubMed ID: 27831925 [TBL] [Abstract][Full Text] [Related]
18. A novel microtubule-modulating noscapinoid triggers apoptosis by inducing spindle multipolarity via centrosome amplification and declustering. Karna P; Rida PC; Pannu V; Gupta KK; Dalton WB; Joshi H; Yang VW; Zhou J; Aneja R Cell Death Differ; 2011 Apr; 18(4):632-44. PubMed ID: 21052096 [TBL] [Abstract][Full Text] [Related]
19. Development of potential anticancer agents and apoptotic inducers based on 4-aryl-4H chromene scaffold: Design, synthesis, biological evaluation and insight on their proliferation inhibition mechanism. Elshemy HAH; Zaki MA; Mahmoud AM; Khan SI; Chittiboyina AG; Kamal AM Bioorg Chem; 2022 Jan; 118():105475. PubMed ID: 34800886 [TBL] [Abstract][Full Text] [Related]
20. Cyclin G2 is a centrosome-associated nucleocytoplasmic shuttling protein that influences microtubule stability and induces a p53-dependent cell cycle arrest. Arachchige Don AS; Dallapiazza RF; Bennin DA; Brake T; Cowan CE; Horne MC Exp Cell Res; 2006 Dec; 312(20):4181-204. PubMed ID: 17123511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]